Government bans sale and manufacture of pain killer Dextropropoxyphene
As per the notification, Government had suspended the manufacture, sale and distribution of Dextropropoxyphene and formulations containing Dextropropoxyphene for human use.
As per notification vide GSR No.332 (E) Dated 23 May 2013 Government had suspended the manufacture, sale and distribution of Dextropropoxyphene and formulations containing Dextropropoxyphene for human use.
Its sale already banned in the US, UK and other countries earlier.
Product permissions granted to the manufacturers and its loan licensees to manufacture this drug and its formulations also stand suspended.
The drug must be withdrawn from the market immediately as per notification of Government of India.
Recent Posts
Regulatory Challenges of SaMD: Navigating Global Standards and Compliance
Navigating Software as a Medical Device regulation involves addressing varying global standards, including risk-based classifications...
The Future of SaMD: Emerging Trends and Innovations
The future of Software as a Medical Device will see breakthroughs in Artificial Intelligence-based diagnostics, personalised treatments, and remote monitoring...
Understanding SaMD: What Makes Software a Medical Device?
Software as a Medical Device refers to software applications designed for medical purposes, such as diagnosis, treatment, or monitoring, without being part of a physical device...
Contact us
Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.